Searchable abstracts of presentations at key conferences in endocrinology

ea0086p189 | Bone and Calcium | SFEBES2022

Denosumab induced recurrent, prolonged and life threatening hypocalcaemia

Tahir Chohan Muhammad , Olaremi Japhet , So Pye Dr , Sony Anthony Dr

Introduction: Denosumab, a human monoclonal antibody used in osteoporosis and second line treatment option for hypercalcaemia, can cause profound hypocalcaemia especially in Vitamin-D depleted and cancer patients.Case history: 56 years female, with diabetes, hypertension on metformin, empagliflozin, amlodipine and ramipril, presented with 3 months history of backache, no red flag signs, clinically and hemodynamically stable except mild confusion and spin...